Study of Biomarkers in Solid Organ and Bone Marrow Transplant Recipients to Better Treat Rejection

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Recipients of abdominal, thoracic and bone marrow allografts that are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center.

• All Ages

• Subject or parents are able to read and understand the informed consent

Locations
United States
Pennsylvania
Children's Hospital of Pittsburgh of UPMC
RECRUITING
Pittsburgh
Contact Information
Primary
Morgan L Paul, BSN
Morgan.Paul2@upmc.edu
412-692-8472
Backup
Daniel Pieratt, MPA
pierattdw@upmc.edu
412-692-6692
Time Frame
Start Date: 2005-03
Estimated Completion Date: 2030-03
Participants
Target number of participants: 1200
Related Therapeutic Areas
Sponsors
Leads: University of Pittsburgh

This content was sourced from clinicaltrials.gov

Similar Clinical Trials